Immunological effects of radiopharmaceutical therapy.

Front Nucl Med · 2024 · PMC11440989 · PMID 39355211

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

approached significancep = 0.059so close (0.05 < p ≤ 0.1)

However, treatment with 600 kBq/kg of 223 RaCl 2 was found to decrease splenic CD8+ T cells ( p = 0.043) significantly and the 50 kBq/kg-treated group approached significance ( p = 0.059) at day 19 post-treatment.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.